M. Gamo

Screening the p53 status of human cell lines using a yeast functional assay

R. Kanamaru, C. Ishioka, M. Akiyama, 1997, Molecular carcinogenesis.

Phase I study of irinotecan by 24-h intravenous infusion in combination with 5-fluorouracil in metastatic colorectal cancer

R. Kanamaru, Y. Ohashi, M. Gamo, 2012, International Journal of Clinical Oncology.

Enhancement of the efficacy of anticancer drugs with electroporation: Successful electrochemotherapy against gastric cancer cell lines in vivo and in vitro

R. Kanamaru, M. Gamo, M. Kambe, 1997, International Journal of Clinical Oncology.

Enhancing the effect of anticancer drugs against the colorectal cancer cell line with electroporation.

R. Kanamaru, M. Gamo, M. Kambe, 1996, The Tohoku journal of experimental medicine.

Oligomerization is not essential for growth suppression by p53 in p53-deficient osteosarcoma Saos-2 cells.

R. Kanamaru, C. Ishioka, C. Englert, 1997, Biochemical and biophysical research communications.

KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin-or irinotecan-based treatment.

S. Kato, C. Ishioka, M. Gamo, 2014, Molecular and clinical oncology.

FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy.

H. Fukuda, R. Kanamaru, C. Ishioka, 1999, Clinical nuclear medicine.